Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 190.04
-2.09 (-1.09%)
Aug 14, 2025, 3:30 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 252.34 billion as of August 14, 2025. Its market cap has increased by 11.78% in one year.
Market Cap
252.34B
Enterprise Value
296.82B
Revenue
91.34B
Ranking
n/a
PE Ratio
259.31
Stock Price
190.04
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 252.34B, an increase of 11.30%. That is a compound annual growth rate of 3.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 255.12B | -27.72% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,934.43B |
| Divi's Laboratories | 1,619.49B |
| Cipla | 1,260.90B |
| Apollo Hospitals Enterprise | 1,122.74B |
| Mankind Pharma | 1,017.79B |
| Zydus Lifesciences | 994.76B |
| Fortis Healthcare | 714.04B |
| Alkem Laboratories | 644.28B |